Home
About
Overview
Sharing Data
ORCID
Help
History (18)
Combining vaccination and postexposure CpG therapy provides optimal protection against lethal sepsis in a biodefense model of human melioidosis.
Rowcroft, Dominique
Chromatography, Gas
Physicians Rarely Elicit Critically Ill Patients' Previously Expressed Treatment Preferences in Intensive Care Units.
Kinases in diabetes. Part II. 11-12 November 2004, Manchester, UK.
See All 18 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Kinases in diabetes. Part II. 11-12 November 2004, Manchester, UK.
Zierath JR. Kinases in diabetes. Part II. 11-12 November 2004, Manchester, UK. IDrugs. 2005 Feb; 8(2):121-3.
View in:
PubMed
subject areas
Animals
Biotechnology
Diabetes Mellitus
Drug Industry
Enzyme Inhibitors
Humans
Insulin
Phosphotransferases
United Kingdom
authors with profiles
Juleen R Zierath PhD